Subscribe to Search results

The team focused on Hepatitis C in the Haemophilia Society declared that hepatitis was not a major concern for the Society. Simon Taylor stated in his evidence to the Inquiry that the Society relied on information from Dr Hay who stated that Hepatitis C was not a concern and Professor Preston's concerns were largely ignored.

Published on:

During oral evidence Penny Mordaunt stated she raised the issue of compensation in her letter dated 13 July 2020 so that all government departments were "aware of what is likely to need to happen and prepare for that." She wanted to give the Treasury "some encouragement to grip the issue".

Published on:

During oral evidence Penny Mordaunt explained she did not receive a written response to her letter dated 13 July 2020.

Published on:

During oral evidence Penny Mordaunt explained it was her expectation that the Government's response to the study commissioned in 2021 to consider a framework for compensation would be published and shared with the Inquiry.

Published on:

During oral evidence Penny Mordaunt agreed that if the acceptance of a moral case for compensation was not followed by action in providing compensation then the Government was not putting it right.

Published on:

During oral evidence Penny Mordaunt described the issue of compensation as "absolutely unprecedented, the length of time that people have had to wait...and things that people have had to deal with that are very difficult to understand."

Published on:

The Inquiry indicated that a second interim report will be published.

Published on:

The Inquiry confirmed that a second interim report would be published.

Published on:

Dr Dempsey continued to use SNBTS concentrates until he became aware of the infection of patients in Edinburgh. He used the heat-treated product NY until July 1987 when the next generation product Z8 became available. He was aware that non-A non-B Hepatitis could still be transmitted by NY.

Published on:

Dr Dempsey would not have used concentrate at all "given what was likely - or what was going to happen further down the road." The NHS product might have been a "better modality of treatment" to have employed back in 1981.

Published on:

Dr Mark Winter said in oral evidence that Dr Preston's 1978 paper about liver disease in people with haemophilia in The Lancet "blew out of the water instantly the idea that this [non-A non-B Hepatitis] was nothing to worry about because their study showed, as did other studies, that most of these patients had very significant chronic liver disease".

Published on:

In his oral evidence, Dr Winter agreed that whilst cryoprecipitate was more laborious to use, it could be used, and had been used, to raise Factor 8 levels. Side effects were for the most part transient.

Published on:

Dr Mark Winter (who regularly read the Morbidity and Mortality Weekly Report) told the Inquiry that: "Any clinician looking at this data would have to believe that AIDS was a transmissible disorder and that it could be transmitted by blood and by blood products."

Published on:

Dr Mark Winter in his oral evidence to the Inquiry described two cases demonstrating how some people with haemophilia were treated elsewhere than at haemophilia centres and the consequences of treatment in such circumstances where those treating might have had limited understanding of the risks of treatment.

Published on:

Dr Winter described how the 1978 Sheffield study showed NANBH to be a really serious evolving clinical problem.

Published on:

Dr Winter described how at the around when the Sheffield study took place most clinicians seemed to ignore the issue of NANBH as blood products has brought such miraculous results and so the issues seemed to outweigh the benefits.

Published on:

Dr Winter stated that that the Preston paper was a key moment as the general attitude moved from mild to very concerned.

Published on:

In oral evidence Dr Mark Winter described how in the 1980s, despite the growing concern of the hepatitis virus, treatment with factor concentrates continued unabated.

Published on:

With respect to the growing prevalence of AIDS and the response of UKHCDO, Dr Winter explained how the issue with blood products was that there were constantly new viruses being discovered.

Published on:

Dr Winter described how the San Francisco cases in 1982 led to the start of haemophilia doctors understanding they were dealing with a transmissible blood disease.

Published on: